Navigation Links
Tighter tummies: A new way to combat weight gain
Date:3/3/2008

Two cell proteins that relax the gut and help accommodate a big meal have been identified by UCL (University College London) scientists. The proteins could offer a future drug target against weight gain, by preventing the stomach from expanding.

In a paper published in this months issue of the Journal of Pharmacology and Experimental Therapeutics, Dr Brian King and Dr Andrea Townsend-Nicholson explored the molecular basis of relaxations of the gut. In the study, the authors identified two protein receptors P2Y1 and P2Y11 involved in fast and slow relaxations of the gut. These proteins were identified in the guinea pig, but are also present in the human gut, and thus offer the potential as a future target for drug treatment. Further research by the UCL team will focus on the human isoform of the P2Y11 protein receptor.

Dr Brian King of the UCL Department of Neuroscience, Physiology and Pharmacology says: The mechanisms we have identified are important to the normal workings of the stomach - a hollow organ which actively relaxes to help accommodate the size of your meal. The human stomach has a resting internal volume of 75 millilitres but, by relaxing its muscular wall, can expand to an internal volume of two litres or more - a 25-fold increase in the volume it can accept. This expansion is controlled by nerves inside the stomach wall and these nerves release molecules that stimulate the P2Y1 and P2Y11 receptor proteins embedded in muscle cells in the gut wall.

The mechanism of slow relaxation of the stomach might represent a future drug target in the fight to control weight gain and reverse obesity. We are looking to identify drugs that would block the P2Y11 receptor and, therefore, prevent slow relaxation of the stomach. As a result of blocking the P2Y11-based mechanism, meal size would be smaller, offering the person a better chance of regulating their food intake.

This would be a brand new approach to weight control.
'/>"/>

Contact: Jenny Gimpel
j.gimpel@ucl.ac.uk
University College London
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Anthem Blue Cross and Blue Shield Teams with the State of Indiana to Combat Obesity
2. Five Years of VA Health Care for Combat Veterans
3. Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade
4. U.S. on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling, Counterfeiting and Other Illicit Trade in Tobacco Products
5. Grapefruit compound may help combat hepatitis C infection
6. ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse
7. Consuming extra virgin olive oil helps to combat degenerative diseases such as cancer
8. Indian medicinal plant Acanthus ilicifolius may combat liver cancer
9. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
10. Global Health Support Service Benchmark Study to Combat Growing Healthcare Costs and Prepare for Likely Health Care Reforms
11. New Academic Analysis Identifies Three Barriers to Achieving Healthy and Achievable Policies to Combat Obesity in America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...ewswire/ -- Governor Edward,G. Rendell today said ...,with high fuel costs and a broken healthcare syst...ergy independence and make healthcare more,afforda...ed to hear the Governor,s message at the,Governmen...nsylvania,s,largest outdoor agricultural expositio...
(Date:8/20/2008)...art of a new generation of neurosurgeons who are m...At Loyola University Hospital, Duckworth is using ...ir life-threatening aneurysms and to dramatically ...han removing large sections of the skull or face, ...er openings. And in certain cases, he goes through...
(Date:8/20/2008).../ -- Yesterday evening,Congresswoman Stephanie Tu...fering an aneurysm while driving her car in Clevel...Jones, condition has stabilized and she is,receivi...followed a full day of activity, including plannin...uled for September 4, 2008,at Cleveland State Univ...
(Date:8/20/2008)...alth technologies designed to,monitor and care for...s in,excess of $1.8 billion by 2013., Technologic...hardware,revenues, according to Parks Associates, ...ogies. Connected medical, activity, and environmen...ring in more than twice the,dollar amount of the l...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2
...entists warn that passive smokings from cigarette ...entists have now detected the cancer-causing chemi...in the urine of nearly half the babies whose paren...e message is, 'Don't smoke around your kids,'" sai...
...tudy states that the organ donation rate in UK is ...ieving relatives are reluctant to allow such proce...re blocking the wishes of potential organ donors b...d about what their loved-ones would have wanted, c...
.... health officials suspect the abortion pill, RU-4...erial infections. //Out of the 6 women who took th...or RU-486 is now expected to be pulled from the sh...ibuted their deaths to the drug. The rare bacteriu...
...ording to a recent study conducted by the research...as found that one in seven East Asian immigrants a...ispose them to conditions such as liver cancer and...t of the people are unaware that they were infecte...
Other Medicine News:Health News:Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke 2Health News:Grieving Relatives Reluctant To Give Consent For Organ Donation 2Health News:East Asian Immigrants Bring Hepatitis to New York 2
(Date:8/19/2008)... Aug. 19 /- Particle Sciences Inc. ha...olymers) development and,pilot production capabili...sion and injection molding line. The core of the p...ng extruder and Nissei 20T injection,molder, enabl...meric,devices. This addition gives Particle Scienc...
(Date:8/19/2008)... 19 /- Vical Incorporated,(...ration with the Karolinska,Institute, a leading Eu...te,for Infectious Disease Control (SMI), a governm...(R) adjuvant with the Biojector(R) 2000,needle-fre...nc.,OTCBB:BJCT) for a multivalent preventive DNA ...
(Date:8/18/2008)...offer hope for increased life expectancy for peopl...wire-USNewswire/ -- In the world of Down,syndrome,... has been,tracked for the past 16 years, at sevent...ectancy of a person with Down syndrome, currently ... was born. Further, ,Mr. C, does,not exhibit clini...
(Date:8/18/2008)... Clinical trial currently in Phase I -, PRINCETON...ra,Therapeutics Inc., a clinical stage biotechnolo...iscovery against life-threatening and life-alterin...e of Patent No. 7,371,772,B2 by the U.S. Patent an...,CCR5 antagonist currently in Phase I development ...
Breaking Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3Body image is stronger predictor of health than obesity says Mailman School of PH study 11719 1Body image is stronger predictor of health than obesity says Mailman School of PH study 11719 2 Respiratory Distress Treatment Studies Conflict 11715 1 Respiratory Distress Treatment Studies Conflict 11715 2 Respiratory Distress Treatment Studies Conflict 11715 3New Jefferson trial to test radiation emitting beads against advanced liver cancer 11710 1New Jefferson trial to test radiation emitting beads against advanced liver cancer 11710 2Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 1Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 2Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 3Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 4
...ed at the Congress of the European Hematology,Asso...tCall/ -- Favrille,Inc. , a biopharmaceutical com...rapies for the treatment of cancer, announced,inte... in patients,with indolent B-cell non-Hodgkin,s ly...ss of the European Hematology Association in,Vienn...
...stria, June 11, 2007 /PRNewswire/ -- GlaxoSmithKli...votal Phase III,study of its investigational non-p...ltrombopag olamine). Data from this study,showed t...tatistically significant increase in platelet coun...h chronic idiopathic,thrombocytopenic purpura (ITP...
Other Medicine Technology:Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
Unit System Slide Cabinet is constructed from hardwood for long lasting.
Shandon Slide File Storage System
Shandon Microscope Slide Trays
... luminance white LED (Light Emitting Diode) light ..., to give you the freedom of using a slit lamp any...t 1.5 lbs. (0.68 kg) with its battery and fits eas...portable design and convenient carrying case make ...
Medicine Products: